Aida Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Sep '08 Sep 30, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003
Cash & Equivalents	8.28	8.4	6.12	3.13	2.81	2.52
Short-Term Investments	-	9.49	0.51	-	-	-
Cash & Short-Term Investments	8.28	17.89	6.63	3.13	2.81	2.52
Cash Growth	7.60%	169.81%	111.90%	11.37%	11.71%	-
Accounts Receivable	10.36	9.66	13.78	9.39	5.13	3.24
Other Receivables	1.65	1.22	0.43	0.96	0.97	1.01
Receivables	13.15	11.87	16.92	13.67	7.99	4.37
Inventory	5.71	4.16	2.93	3.67	2.83	3.15
Restricted Cash	0.87	0.89	1.98	1.9	0.26	-
Other Current Assets	1.7	1.06	0.82	0.04	4.4	0.02
Total Current Assets	32.28	36.28	29.58	22.41	18.28	10.13
Property, Plant & Equipment	20.79	17.02	14.01	12.84	3.57	5.04
Long-Term Investments	0.54	0.21	0.3	0.22	0.64	0.64
Other Intangible Assets	20.08	9.03	9.47	3.54	0.77	0.86
Long-Term Deferred Tax Assets	0.22	0.2	0.46	0.21	0.21	0.21
Other Long-Term Assets	-	-	-	3.43	1.76	0.92
Total Assets	73.99	62.73	53.81	42.66	25.25	17.81
Accounts Payable	3.01	2.55	3.33	1.62	0.85	0.82
Accrued Expenses	0.55	0.41	0.42	0.64	0.01	-
Short-Term Debt	31.2	30.39	23.94	21.61	9.78	7.45
Current Portion of Long-Term Debt	1.37	1.37	-	-	-	-
Current Income Taxes Payable	0.18	0.13	0.35	0.04	-	0.51
Current Unearned Revenue	1.49	1.03	0.25	-	-	-
Other Current Liabilities	6.44	2.85	2.18	4.25	6.57	2.61
Total Current Liabilities	44.37	38.87	30.66	28.26	17.31	11.46
Long-Term Debt	8.61	1.65	5.64	3.72	1.09	1.21
Long-Term Unearned Revenue	0.06	0.05	1.07	-	-	-
Long-Term Deferred Tax Liabilities	3.62	0.97	1.02	0.39	0.17	0.16
Total Liabilities	56.65	41.54	38.38	32.37	18.58	12.83
Common Stock	0.03	0.03	0.03	0.03	0.02	2.48
Additional Paid-In Capital	5.4	5.2	5.2	3.42	3.42	-
Retained Earnings	2.74	7.33	4.59	3.14	1.67	1.78
Comprehensive Income & Other	0.98	0.76	0.43	0.14	0	0
Total Common Equity	9.16	13.32	10.25	6.72	5.11	4.26
Minority Interest	8.18	7.87	5.18	3.57	1.56	0.72
Shareholders' Equity	17.34	21.19	15.43	10.29	6.67	4.98
Total Liabilities & Equity	73.99	62.73	53.81	42.66	25.25	17.81
Total Debt	41.17	33.41	29.58	25.33	10.87	8.66
Net Cash (Debt)	-32.9	-15.52	-22.95	-22.2	-8.06	-6.15
Net Cash Per Share	-1.22	-0.57	-0.88	-0.95	-0.34	-
Filing Date Shares Outstanding	27	27	27	25	23.38	-
Total Common Shares Outstanding	27	27	27	25	23.38	-
Working Capital	-12.09	-2.59	-1.08	-5.85	0.97	-1.33
Book Value Per Share	0.34	0.49	0.38	0.27	0.22	-
Tangible Book Value	-10.93	4.29	0.78	3.18	4.34	3.39
Tangible Book Value Per Share	-0.40	0.16	0.03	0.13	0.19	-
Buildings	11.13	9.87	8.94	6.94	2.49	2.47
Machinery	16.55	14.29	10.62	9.01	3.09	3.23
Construction In Progress	2.17	0.27	0.03	0.86	-	1.17
Leasehold Improvements	0.52	0.48	0.46	0.37	0.11	0.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.